NewEdge Advisors’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$615K Buy
148,931
+62,046
+71% +$268K ﹤0.01% 2008
2026
Q1
$321K Buy
86,885
+85,885
+8,589% +$361K ﹤0.01% 2292
2025
Q4
$3.45K Hold
1,000
﹤0.01% 3771
2025
Q3
$5.11K Hold
1,000
﹤0.01% 3528
2025
Q2
$5.29K Hold
1,000
﹤0.01% 3394
2025
Q1
$8.14K Hold
1,000
﹤0.01% 3171
2024
Q4
$12.8K Buy
+1,000
New +$11.8K ﹤0.01% 2955

Other funds holding RCEL

NewEdge Advisors's RCEL Position: Q2 2026 in Review

NewEdge Advisors increased its Avita Medical (RCEL) stake by 71% in Q2 2026, buying an estimated $268K and bringing the position to 148,931 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

NewEdge Advisors first reported a position in RCEL in Q4 2024 and has held it in 7 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • NewEdge Advisors held 148,931 shares of Avita Medical worth $615K as of Q2 2026.
  • NewEdge Advisors bought 62,046 Avita Medical shares in Q2 2026, an estimated $268K.
  • Avita Medical made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2008 holding.
  • NewEdge Advisors first reported a position in Avita Medical in Q4 2024 and has held it in 7 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.